NTLA
Price
$6.63
Change
-$0.26 (-3.77%)
Updated
Apr 4 closing price
Capitalization
686.32M
25 days until earnings call
SLN
Price
$2.61
Change
-$0.13 (-4.74%)
Updated
Apr 4 closing price
Capitalization
120.42M
Ad is loading...

NTLA vs SLN

Header iconNTLA vs SLN Comparison
Open Charts NTLA vs SLNBanner chart's image
Intellia Therapeutics
Price$6.63
Change-$0.26 (-3.77%)
Volume$4.81M
Capitalization686.32M
Silence Therapeutics
Price$2.61
Change-$0.13 (-4.74%)
Volume$239.38K
Capitalization120.42M
NTLA vs SLN Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTLA vs. SLN commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Hold and SLN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (NTLA: $6.63 vs. SLN: $2.61)
Brand notoriety: NTLA and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 140% vs. SLN: 90%
Market capitalization -- NTLA: $686.32M vs. SLN: $120.42M
NTLA [@Biotechnology] is valued at $686.32M. SLN’s [@Biotechnology] market capitalization is $120.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both NTLA and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 4 TA indicator(s) are bullish while SLN’s TA Score has 4 bullish TA indicator(s).

  • NTLA’s TA Score: 4 bullish, 5 bearish.
  • SLN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLN is a better buy in the short-term than NTLA.

Price Growth

NTLA (@Biotechnology) experienced а -17.84% price change this week, while SLN (@Biotechnology) price change was -24.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Reported Earning Dates

NTLA is expected to report earnings on Jul 31, 2025.

SLN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($686M) has a higher market cap than SLN($120M). NTLA YTD gains are higher at: -43.139 vs. SLN (-62.064). SLN has higher annual earnings (EBITDA): -48.99M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. SLN (147M). SLN has less debt than NTLA: SLN (117K) vs NTLA (210M). NTLA has higher revenues than SLN: NTLA (57.9M) vs SLN (43.3M).
NTLASLNNTLA / SLN
Capitalization686M120M572%
EBITDA-523.98M-48.99M1,070%
Gain YTD-43.139-62.06470%
P/E RatioN/AN/A-
Revenue57.9M43.3M134%
Total Cash602M147M410%
Total Debt210M117K179,487%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLASLN
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend about 1 month ago
90%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMSTX12.27-0.73
-5.62%
MFS Blended Research Mid Cap Eq R3
MIVIX26.10-1.58
-5.71%
Madison Large Cap I
HMDYX28.54-1.75
-5.78%
Hartford MidCap Y
GMCFX25.03-1.75
-6.53%
GMO International Equity IV
ULPSX72.71-9.85
-11.93%
ProFunds UltraBull Svc